Invention Grant
- Patent Title: Method for the treatment of epilepsy, epileptogenesis, seizures or convulsions by an anti-colony-stimulating factor 1 receptor (CSF-1R) antibody
-
Application No.: US15577035Application Date: 2016-05-25
-
Publication No.: US10316097B2Publication Date: 2019-06-11
- Inventor: Patrice Marie Charles Godard , Rafal Marian Kaminski , Karine Josee Jeanne Leclercq , Jonathan Marie M Van Eyll
- Applicant: UCB BIOPHARMA SPRL
- Applicant Address: BE Brussels
- Assignee: UCB BIOPHARMA SPRL
- Current Assignee: UCB BIOPHARMA SPRL
- Current Assignee Address: BE Brussels
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP15169367 20150527
- International Application: PCT/EP2016/061824 WO 20160525
- International Announcement: WO2016/189045 WO 20161201
- Main IPC: G01N33/53
- IPC: G01N33/53 ; A61K39/395 ; C07K14/475 ; C07K14/48 ; A61K38/00 ; A61K38/18 ; A61K49/00 ; A61K49/16 ; A61K38/19 ; A61K38/20 ; A61K38/21 ; A61K38/17 ; C07K14/47 ; C07K16/28 ; A61P25/28 ; A61P25/18 ; A61P25/16 ; A61K39/00
Abstract:
The present invention pertain an inhibitor of CSF-1R activity for use in the treatment and/or prophylaxis of neurologic diseases and new method of treatment of neurologic diseases.
Public/Granted literature
- US20180142026A1 METHOD FOR THE TREATMENT OF NEUROLOGICAL DISEASE Public/Granted day:2018-05-24
Information query
IPC分类:
